Affymax Seeks FDA Approval For Dialysis Drug

REPLAY VIDEO
Your next video will start in
Pause

Recommended Videos

  • Info

  • Comments

June 27 (Bloomberg) -- John Orwin, chief executive officer of Affymax Inc., talks about the company's efforts to secure FDA approval for its first product, a drug used in the treatment of kidney dialysis patients with anemia. Orwin also discusses drug pricing strategy. Orwin speaks with Shannon Pettypiece at the 2011 BIO International Convention in Washington on Bloomberg Television's "Street Smart." (Source: Bloomberg)

Advertisement

BTV Channel Finder

Channel_finder_loader

ZIP is required for U.S. locations

Bloomberg Television in   change